Literature DB >> 31801710

[Subgroup identification based on an accelerated failure time model combined with adaptive elastic net].

Pei Kang1, Jun Xu2, Fuqiang Huang1, Yingxin Liu1, Shengli An1.   

Abstract

OBJECTIVE: We propose a strategy for identifying subgroups with the treatment effect from the survival data of a randomized clinical trial based on accelerated failure time (AFT) model.
METHODS: We applied adaptive elastic net to the AFT model (designated as the penalized model) and identified the candidate covariates based on covariate-treatment interactions. To classify the patient subgroups, we utilized a likelihood-based change-point algorithm to determine the threshold cutoff point. A two-stage adaptive design was adopted to verify if the treatment effect existed within the identified subgroups.
RESULTS: The penalized model with the main effect of the covariates considerably outperformed the univariate model without the main effect for the trial data with a small sample size, a high censoring rate, a small subgroup size, or a sample size that did not exceed the number of covariates; in other scenarios, the latter model showed better performances. Compared with the traditional design, the adaptive design improved the power for detecting the treatment effect where subgroup effect exists with a well-controlled type Ⅰ error.
CONCLUSIONS: The penalized AFT model with the main effect of the covariates has advantages in subgroup identification from the survival data of clinical trials. Compared with the traditional design, the two-stage adaptive design has better performance in evaluation of the treatment effect when a subgroup effect exists.

Entities:  

Keywords:  accelerated failure time model; adaptive design; adaptive elastic net; change-point algorithm; precision medicine

Mesh:

Year:  2019        PMID: 31801710      PMCID: PMC6867947          DOI: 10.12122/j.issn.1673-4254.2019.10.11

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  19 in total

1.  Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.

Authors:  Sara T Brookes; Elise Whitely; Matthias Egger; George Davey Smith; Paul A Mulheran; Tim J Peters
Journal:  J Clin Epidemiol       Date:  2004-03       Impact factor: 6.437

Review 2.  Predictive biomarkers for treatment selection: statistical considerations.

Authors:  James J Chen; Tzu-Pin Lu; Yu-Chuan Chen; Wei-Jiun Lin
Journal:  Biomark Med       Date:  2015-10-28       Impact factor: 2.851

3.  Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients.

Authors:  Boris Freidlin; Richard Simon
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

4.  Analysis of randomized comparative clinical trial data for personalized treatment selections.

Authors:  Tianxi Cai; Lu Tian; Peggy H Wong; L J Wei
Journal:  Biostatistics       Date:  2010-09-28       Impact factor: 5.899

5.  Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.

Authors:  Ilya Lipkovich; Alex Dmitrienko; Jonathan Denne; Gregory Enas
Journal:  Stat Med       Date:  2011-07-22       Impact factor: 2.373

6.  Concordance measure and discriminatory accuracy in transformation cure models.

Authors:  Yilong Zhang; Yongzhao Shao
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

7.  ON THE ADAPTIVE ELASTIC-NET WITH A DIVERGING NUMBER OF PARAMETERS.

Authors:  Hui Zou; Hao Helen Zhang
Journal:  Ann Stat       Date:  2009       Impact factor: 4.028

8.  Development of predictive signatures for treatment selection in precision medicine with survival outcomes.

Authors:  Yu-Chuan Chen; Un Jung Lee; Chen-An Tsai; James J Chen
Journal:  Pharm Stat       Date:  2018-01-03       Impact factor: 1.894

9.  Cure models as a useful statistical tool for analyzing survival.

Authors:  Megan Othus; Bart Barlogie; Michael L Leblanc; John J Crowley
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

10.  Survival analysis with high-dimensional covariates: an application in microarray studies.

Authors:  David Engler; Yi Li
Journal:  Stat Appl Genet Mol Biol       Date:  2009-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.